Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Late Clearance of Circulating Leukemic Blasts (CBs) During Induction Therapy (IT) Is a predictive of Refractory Adult Acute Myeloid Leukemia (AML)

Alaa Muslimani, MD, Aya Rifai, MD, Mohammad Muhsin Muhsin Chisti, MD, Jeffery Margolis, MD, Laura Nadeau, MD, Ishmael Jaiyesimi, DO, James Huang, MD

Blood (2012) 120 (21): 4319.

https://doi.org/10.1182/blood.V120.21.4319.4319

Published: 2012

Journal Articles

Venous Thrombotic Events (VTEs) in Acute Myeloid Leukemia (AML) Patients During Induction Therapy (IT): Identifying Risk Factors, and Safety of Using Anticoagulation Therapy

Alaa Muslimani, MD, Aya Rifai, MD, Mohammad Muhsin Chisti, MD, Ayham Ashkar, MD, Kinda Muslemani, MD, Jeffery Margolis, MD, Laura Nadeau, MD, Hong Ye, MS, Mark Micale, PhD, James Huang, MD, Ishmael Jaiyesimi, DO

Blood (2011) 118 (21): 3148.

https://doi.org/10.1182/blood.V118.21.3148.3148

Published: 2011

Journal Articles

Pulmonary Infiltrates (PI) in Acute Myeloid Leukemia (AML) During Induction Treatment (IT). How Much Do We Know?

Alaa Muslimani, MD, Mohammad Muhsin Chisti, MD, Jeffery Margolis, MD, Laura Nadeau, MD, Hong Ye, MS, Mark Micale, PhD, James Huang, MD, Ishmael Jaiyesimi, DO

Blood (2011) 118 (21): 2087.

https://doi.org/10.1182/blood.V118.21.2087.2087

Published: 2011

Journal Articles

Evaluation of the Diagnostic Utility of Cerebral Spinal Fluid (CSF) Flow Cytometry (FC) In Detection of Central Nervous System (CNS) Involvement by Hematological Malignancy.

Alaa Muslimani, MD, Sani Kizilbash, MD, Ishmael Jaiyesimi, DO, Laura Nadeau, MD, Dana Zakalik, MD, Jeffery Margolis, MD, James Huang, MD

Blood (2010) 116 (21): 3837.

https://doi.org/10.1182/blood.V116.21.3837.3837

Published: 2010

Journal Articles

Lymphoma and Peripheral Neuropathy: Sudden Weakness in a Patient with T-Cell Lymphoma.

Alaa Muslimani, MD, Hamed Daw, M.D

Blood (2006) 108 (11): 5326.

https://doi.org/10.1182/blood.V108.11.5326.5326

Published: 2006

Journal Articles

Using Recombinant Activated Factor VII (rFVIIa) in Refractory Bleeding: A Community Hospital Experience.

Alaa Muslimani, MD, Hamed Daw, M.D

Blood (2006) 108 (11): 4048.

https://doi.org/10.1182/blood.V108.11.4048.4048

Published: 2006

Journal Articles

Secondary Myelodysplastic Syndrome after Hydroxychloroquine Therapy.

Alaa Muslimani, MD, Timothy Spiro, MD,FACP, Asif Chaudhry, M.D, Daw Hamed, M.D

Blood (2006) 108 (11): 4829.

https://doi.org/10.1182/blood.V108.11.4829.4829

Published: 2006

Journal Articles

Thalidomide in Multiple Myeloma - A Community Hospital Experience.

Homayoun Leon Daneschvar, MD, Hamed Daw, MD, Asif Chaudhry, MD, Harris Taylor, MD, Manmeet Ahluwalia, MD, Ish Rawal, MD, Alaa Muslimani, MD

Blood (2005) 106 (11): 5140.

https://doi.org/10.1182/blood.V106.11.5140.5140

Published: 2005

NARROW

Late Clearance of Circulating Leukemic Blasts (CBs) During Induction Therapy (IT) Is a predictive of Refractory Adult Acute Myeloid Leukemia (AML)

Venous Thrombotic Events (VTEs) in Acute Myeloid Leukemia (AML) Patients During Induction Therapy (IT): Identifying Risk Factors, and Safety of Using Anticoagulation Therapy

Pulmonary Infiltrates (PI) in Acute Myeloid Leukemia (AML) During Induction Treatment (IT). How Much Do We Know?

Evaluation of the Diagnostic Utility of Cerebral Spinal Fluid (CSF) Flow Cytometry (FC) In Detection of Central Nervous System (CNS) Involvement by Hematological Malignancy.

Lymphoma and Peripheral Neuropathy: Sudden Weakness in a Patient with T-Cell Lymphoma.

Using Recombinant Activated Factor VII (rFVIIa) in Refractory Bleeding: A Community Hospital Experience.

Secondary Myelodysplastic Syndrome after Hydroxychloroquine Therapy.

Thalidomide in Multiple Myeloma - A Community Hospital Experience.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only